[{"data":1,"prerenderedAt":25},["ShallowReactive",2],{"project-3a0f6afa69ef5fe400dc0c0b320f204f":3},{"_id":4,"slug":4,"title":5,"subtitle":6,"cover":8,"tech_type":9,"indications":10,"official_price":11,"hospital_name":12,"hospital_names":13,"tech_company_name":12,"view_count":14,"favorite_count":15,"is_favorite":16,"approval_no":17,"approval_date":9,"regulatory_level":18,"valid_until":9,"filing_date":19,"intro":20,"detail_desc":21,"target_population":22,"compliance_list":23,"process":24},"3a0f6afa69ef5fe400dc0c0b320f204f","抗 EB 病毒感染的细胞疫苗治疗技术",[7],"EBV 感染相关疾病","https://6875-huali-cell-8geyb3yje6a285d1-1419749029.tcb.qcloud.la/assets/cover/1778467749973-009抗EB病毒感染的细胞疫苗治疗技术.jpg","",[7],"1.6万元/次*5针 (8万/疗程)","成都臻愈生物医药科技有限公司",[],38,1,false,"乐城第三批获批","低风险","2025年","\u003Cp>EB病毒感染相关疾病\u003Cspan style=\"color: var(--color-text-primary, #1a2035); font-family: var(--font-family-base, -apple-system, BlinkMacSystemFont, "PingFang SC", "Microsoft YaHei", "Segoe UI", sans-serif);\">_(EBV-DNA＞50 copies/mL)\u003C/span>\u003C/p>\u003Cp>\u003Cspan style=\"color: var(--color-text-primary, #1a2035); font-family: var(--font-family-base, -apple-system, BlinkMacSystemFont, "PingFang SC", "Microsoft YaHei", "Segoe UI", sans-serif);\">抗 EB 病毒特异性 T 细胞疫苗用于 EBV 相关淋巴增殖、鼻咽癌等。\u003C/span>\u003C/p>\u003Cp>\u003Cb>适应症\u003C/b>:EBV 病毒感染相关疾病\u003Cbr>\u003Cb>技术类型\u003C/b>:特许疫苗\u003Cbr>\u003Cb>批次\u003C/b>:乐城第三批获批\u003C/p>","抗 EB 病毒特异性 T 细胞疫苗用于 EBV 相关淋巴增殖、鼻咽癌等。",[],[],[],1779368115444]